Evidence map›Paper›PMID 26365382›Full record

ArticleMolecular cell2015

USP7 Acts as a Molecular Rheostat to Promote WASH-Dependent Endosomal Protein Recycling and Is Mutated in a Human Neurodevelopmental Disorder.

Yi-Heng Hao, Michael D Fountain, Klementina Fon Tacer, Fan Xia, Weimin Bi, Sung-Hae L Kang, Ankita Patel, Jill A Rosenfeld, Cédric Le Caignec, Bertrand Isidor and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 133 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
133citing papers in PubMed, 1 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

133 citing papers in PubMed, 1 synthesis or guideline pooled it, 201 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Small-molecule allosteric activator of ubiquitin-specific protease 7 (USP7).Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

73 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 2 countries.

Yi-Heng HaoDepartments of Physiology, Pharmacology, and Biochemistry, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Michael D FountainTranslational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX 77030, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX 77030, USA.
Klementina Fon TacerDepartments of Physiology, Pharmacology, and Biochemistry, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Fan XiaDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Weimin BiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Sung-Hae L KangDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Ankita PatelDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Jill A RosenfeldSignature Genomics, Spokane, WA 99207, USA.
Cédric Le CaignecService de Génétique Médicale, CHU de Nantes, Nantes 44093, France.
Bertrand IsidorService de Génétique Médicale, CHU de Nantes, Nantes 44093, France.
Ian D KrantzDivision of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Sarah E NoonDivision of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Jean P PfotenhauerDivision of Medical Genetics and Genomic Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Thomas M MorganDivision of Medical Genetics and Genomic Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Rocio MoranGenomic Medicine Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Robert C PedersenDepartment of Pediatrics, Tripler Army Medical Center, Honolulu, HI 96859, USA.
Margarita S SaenzClinical Genetics and Metabolism, Children's Hospital Colorado, Aurora, CO 80045, USA.
Christian P SchaafTranslational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX 77030, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX 77030, USA. Electronic address: schaaf@bcm.edu.
Patrick Ryan PottsDepartments of Physiology, Pharmacology, and Biochemistry, UT Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address: ryan.potts@utsouthwestern.edu.
Baylor College of Medicine · USVanderbilt University · USCentre Hospitalier Universitaire de Nantes · FRChildren's Hospital Colorado · USChildren's Hospital of Philadelphia · USCleveland Clinic · USGénétique Médicale & Génomique Fonctionelle · FRSignature Analytics (United States) · USSouthwestern Medical CenterSouthwestern Medical Center · USTripler Army Medical Center · US

Funding

UNDERSTANDING FXTAS AMONG MALES WITH THE FMR1 PREMUTATIONP30HD024064 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI TOLIAS, KIMBERLY R · 1988 to 2013
$29.4M
Steps towards a paternal gene activation therapy for Angelman syndromeU54HD083092 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI BEAUDET, ARTHUR L., NELSON, DAVID LOREN · 2014 to 2019
$7.8M
Regulation of WASH-mediated Endosomal Protein RecyclingR01GM111332 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI POTTS, PATRICK RYAN · 2015 to 2019
$1.7M
NICHD NIH HHS 1U54 HD083092NICHD NIH HHS P30 HD024064NICHD NIH HHS U54 HD083092NIGMS NIH HHS R01 GM111332NIGMS NIH HHS R01GM111332Wellcome Trust
6 · The paper itself

Abstract

Endosomal protein recycling is a fundamental cellular process important for cellular homeostasis, signaling, and fate determination that is implicated in several diseases. WASH is an actin-nucleating protein essential for this process, and its activity is controlled through K63-linked ubiquitination by the MAGE-L2-TRIM27 ubiquitin ligase. Here, we show that the USP7 deubiquitinating enzyme is an integral component of the MAGE-L2-TRIM27 ligase and is essential for WASH-mediated endosomal actin assembly and protein recycling. Mechanistically, USP7 acts as a molecular rheostat to precisely fine-tune endosomal F-actin levels by counteracting TRIM27 auto-ubiquitination/degradation and preventing overactivation of WASH through directly deubiquitinating it. Importantly, we identify de novo heterozygous loss-of-function mutations of USP7 in individuals with a neurodevelopmental disorder, featuring intellectual disability and autism spectrum disorder. These results provide unanticipated insights into endosomal trafficking, illuminate the cooperativity between an ubiquitin ligase and a deubiquitinating enzyme, and establish a role for USP7 in human neurodevelopmental disease.

Indexed as

AdolescentAutism Spectrum DisorderChildChild, PreschoolDNA-Binding ProteinsEndosomesFeedback, PhysiologicalFemaleHaploinsufficiencyHCT116 CellsHumansHypothalamusIntellectual DisabilityMaleMicrofilament ProteinsNeuronsDNA-Binding ProteinsMicrofilament ProteinsNuclear ProteinsTRIM27 protein, humanTripartite Motif ProteinsUbiquitin-Specific Peptidase 7Ubiquitin ThiolesteraseUSP7 protein, humanWASH protein, human

Identifiers

PMID26365382
PMCPMC4575888
OpenAlexW1843647340

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.